These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 32980763)

  • 21. Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy.
    Aouad MT; Alfahel WS; Kaddoum RN; Siddik-Sayyid SM
    BMC Anesthesiol; 2017 Apr; 17(1):57. PubMed ID: 28399799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-Dose or High-Dose Rocuronium Reversed with Neostigmine or Sugammadex for Cesarean Delivery Anesthesia: A Randomized Controlled Noninferiority Trial of Time to Tracheal Intubation and Extubation.
    Stourac P; Adamus M; Seidlova D; Pavlik T; Janku P; Krikava I; Mrozek Z; Prochazka M; Klucka J; Stoudek R; Bartikova I; Kosinova M; Harazim H; Robotkova H; Hejduk K; Hodicka Z; Kirchnerova M; Francakova J; Obare Pyszkova L; Hlozkova J; Sevcik P
    Anesth Analg; 2016 May; 122(5):1536-45. PubMed ID: 26974018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER): A Multicenter Matched Cohort Analysis.
    Kheterpal S; Vaughn MT; Dubovoy TZ; Shah NJ; Bash LD; Colquhoun DA; Shanks AM; Mathis MR; Soto RG; Bardia A; Bartels K; McCormick PJ; Schonberger RB; Saager L
    Anesthesiology; 2020 Jun; 132(6):1371-1381. PubMed ID: 32282427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Half-Dose Sugammadex After Neostigmine Versus Neostigmine as a Routine Reversal Agent: A Pilot Randomized Trial.
    Baysal A; Sagıroglu G; Dogukan M; Ozkaynak I
    J Perianesth Nurs; 2022 Jun; 37(3):326-332. PubMed ID: 35153119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the effects of sugammadex versus neostigmine for reversal of neuromuscular block on hospital costs of care.
    Wachtendorf LJ; Tartler TM; Ahrens E; Witt AS; Azimaraghi O; Fassbender P; Suleiman A; Linhardt FC; Blank M; Nabel SY; Chao JY; Goriacko P; Mirhaji P; Houle TT; Schaefer MS; Eikermann M
    Br J Anaesth; 2023 Feb; 130(2):133-141. PubMed ID: 36564246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of sugammadex on incidence of postoperative residual neuromuscular blockade: a randomized, controlled study.
    Brueckmann B; Sasaki N; Grobara P; Li MK; Woo T; de Bie J; Maktabi M; Lee J; Kwo J; Pino R; Sabouri AS; McGovern F; Staehr-Rye AK; Eikermann M
    Br J Anaesth; 2015 Nov; 115(5):743-51. PubMed ID: 25935840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of reversal of neuromuscular blockade with sugammadex or neostigmine on postoperative quality of recovery following a single bolus dose of rocuronium: A prospective, randomized, double-blinded, controlled study.
    Kim NY; Koh JC; Lee KY; Kim SS; Hong JH; Nam HJ; Bai SJ
    J Clin Anesth; 2019 Nov; 57():97-102. PubMed ID: 30939422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sugammadex for reversal of neuromuscular blockade in pediatric patients: Results from a phase IV randomized study.
    Voss T; Wang A; DeAngelis M; Speek M; Saldien V; Hammer GB; Wrishko R; Herring WJ
    Paediatr Anaesth; 2022 Mar; 32(3):436-445. PubMed ID: 34878707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sugammadex Versus Neostigmine for Reversal of Rocuronium Neuromuscular Block in Patients Having Catheter-Based Neurointerventional Procedures: A Randomized Trial.
    Farag E; Rivas E; Bravo M; Hussain S; Argalious M; Khanna S; Seif J; Pu X; Mao G; Bain M; Elgabaly M; Esa WAS; Sessler DI
    Anesth Analg; 2021 Jun; 132(6):1666-1676. PubMed ID: 34032663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimizing Reversal of Neuromuscular Block in Older Adults: Sugammadex or Neostigmine.
    Togioka BM; Schenning KJ
    Drugs Aging; 2022 Oct; 39(10):749-761. PubMed ID: 35934764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuromuscular Blockade and Reversal Agent Practice Variability in the US Inpatient Surgical Settings.
    Bash LD; Turzhitsky V; Black W; Urman RD
    Adv Ther; 2021 Sep; 38(9):4736-4755. PubMed ID: 34319550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of rocuronium-induced intense neuromuscular blockade by sugammadex in Korean children: A pharmacokinetic and pharmacodynamic analysis.
    Ji SH; Huh KY; Oh J; Jeong HJ; Jang YE; Kim EH; Lee JH; Kim JT; Kim HS
    Clin Transl Sci; 2023 Jan; 16(1):92-103. PubMed ID: 36181377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversal of rocuronium induced neuromuscular block with sugammadex or neostigmine: a large observational study.
    Della Rocca G; Pompei L; Pagan DE Paganis C; Tesoro S; Mendola C; Boninsegni P; Tempia A; Manstretta S; Zamidei L; Gratarola A; Murabito P; Fuggiano L; DI Marco P
    Acta Anaesthesiol Scand; 2013 Oct; 57(9):1138-45. PubMed ID: 23849107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Problem of neuromuscular block reversion: neostigmine and sugammadex].
    Mizikov VM; Stamov VI; Deshko IuV; Ialich AIu
    Anesteziol Reanimatol; 2010; (2):40-3. PubMed ID: 20524330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sugammadex for reversal of neuromuscular blockade: a retrospective analysis of clinical outcomes and cost-effectiveness in a single center.
    Carron M; Baratto F; Zarantonello F; Ori C
    Clinicoecon Outcomes Res; 2016; 8():43-52. PubMed ID: 26937203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of sugammadex for reversal of neuromuscular block.
    Honing G; Martini CH; Bom A; van Velzen M; Niesters M; Aarts L; Dahan A; Boon M
    Expert Opin Drug Saf; 2019 Oct; 18(10):883-891. PubMed ID: 31359807
    [No Abstract]   [Full Text] [Related]  

  • 37. Sugammadex Versus Neostigmine for Neuromuscular Block Reversal and Postoperative Pulmonary Complications in Patients Undergoing Resection of Lung Cancer.
    Yu Y; Wang H; Bao Q; Zhang T; Chen B; Ding J
    J Cardiothorac Vasc Anesth; 2022 Sep; 36(9):3626-3633. PubMed ID: 35662514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retrospective Analysis of the Safety and Efficacy of Sugammadex Versus Neostigmine for the Reversal of Neuromuscular Blockade in Children.
    Gaver RS; Brenn BR; Gartley A; Donahue BS
    Anesth Analg; 2019 Oct; 129(4):1124-1129. PubMed ID: 31584918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case Report: Successful Reversal of Residual Block with Sugammadex in a Patient Not Known to Have Myasthenia Gravis.
    Kuo KC; Wong CS; Wu TJ
    Am J Case Rep; 2022 Oct; 23():e937128. PubMed ID: 36229945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recovery characteristics of patients receiving either sugammadex or neostigmine and glycopyrrolate for reversal of neuromuscular block: a randomised controlled trial.
    Paech MJ; Kaye R; Baber C; Nathan EA
    Anaesthesia; 2018 Mar; 73(3):340-347. PubMed ID: 29214645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.